BioCentury
ARTICLE | Financial News

Twist tops off $60 million round

June 14, 2017 8:39 PM UTC

Synthetic DNA company Twist Bioscience Corp. (San Francisco, Calif.) raised $27 million in the second close of a venture round, bringing the round's total to $60 million. The round's series was not disclosed. The company announced a $61 million series D round in January 2016.

Investors in the new round included Biomatics Capital, Reinet Fund, NFT Investments, Kangmei Group, Bay City Capital, GF Xinde Life Science Investment Fund, 3W Partners Capital and Ditch Plains Capital Management...

BCIQ Company Profiles

Twist Bioscience Corp.